3/11
01:27 pm
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Medium
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
2/13
09:19 am
jspr
Rating for JSPR
Medium
Report
Rating for JSPR
2/13
08:12 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $38.00 price target on the stock.
Medium
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $38.00 price target on the stock.
2/13
07:53 am
jspr
Jasper Therapeutics initiated with a Buy at UBS
Medium
Report
Jasper Therapeutics initiated with a Buy at UBS
1/10
10:41 am
jspr
Rating for JSPR
Medium
Report
Rating for JSPR
1/10
10:41 am
jspr
Rating for JSPR
Medium
Report
Rating for JSPR
1/9
10:24 am
jspr
Rating for JSPR
Report
Rating for JSPR
1/9
10:24 am
jspr
Rating for JSPR
Report
Rating for JSPR
1/6
08:44 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $70.00 price target on the stock.
Medium
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $70.00 price target on the stock.
1/6
08:44 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $70.00 price target on the stock.
Medium
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $70.00 price target on the stock.
1/6
08:27 am
jspr
Rating for JSPR
Medium
Report
Rating for JSPR
1/6
08:27 am
jspr
Rating for JSPR
Medium
Report
Rating for JSPR